1 Result(s)

Article

Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8⁺ T and NK cell function

Pegylated interferon-alpha (PegIFNα) therapy has limited effectiveness in hepatitis B e-antigen (HBeAg)-positive chronic hepatitis B (CHB) patients. However, the mechanism underlying this failure is poorly und...

Zhen Xun, **piao Lin, Qingqing Yu, Can Liu… in Cellular & Molecular Immunology (2021)